PTPRC and systemic lupus erythematosus: Ct-CD45 is present at high levels in human plasma during the steady state but is significantly reduced in plasma derived from patients suffering from Systemic Lupus Erythematosus (SLE) or RA, which suggests that ct-CD45 contributes to the pathogenesis of these autoimmune diseases [4].